Friday, July 26, 2013 9:22:51 AM
Lots of newbies with their little agenda's..........
Liabilities
Accounts Payable 377 -- 703 1,140 853
Payable/Accrued 0 3,891 1,681 20 187
Accrued Expenses 1,390 299 2,886 4,238 3,735
Notes Payable/ST Debt 12,109 12,115 0 0 0
Customer Advances 524 270 796 468 742
Other Current Liabilities 310 2,775 371 5,176 2,860
Other Curr. Lblts, Total 834 3,045 1,167 5,644 3,602
Total Current Liabilities 14,710 19,350 6,437 11,043 8,377
Total Long Term Debt 0 0 0 0 0
Total Debt 12,109 12,115 0 0 0
Deferred Income Tax 887 0 53 79 164
Minority Interest 0 623 598 547 503
Other Liabilities, Total 4,284 94 2,477 2,123 1,740
Total Liabilities 19,881 20,067 9,564 13,792 10,784
Liabilities
Accounts Payable 377 -- 703 1,140 853
Payable/Accrued 0 3,891 1,681 20 187
Accrued Expenses 1,390 299 2,886 4,238 3,735
Notes Payable/ST Debt 12,109 12,115 0 0 0
Customer Advances 524 270 796 468 742
Other Current Liabilities 310 2,775 371 5,176 2,860
Other Curr. Lblts, Total 834 3,045 1,167 5,644 3,602
Total Current Liabilities 14,710 19,350 6,437 11,043 8,377
Total Long Term Debt 0 0 0 0 0
Total Debt 12,109 12,115 0 0 0
Deferred Income Tax 887 0 53 79 164
Minority Interest 0 623 598 547 503
Other Liabilities, Total 4,284 94 2,477 2,123 1,740
Total Liabilities 19,881 20,067 9,564 13,792 10,784
Recent INO News
- INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 04/06/2026 07:46:00 AM
- INOVIO Announces Pricing of $17.5 Million Public Offering • PR Newswire (US) • 04/02/2026 12:55:00 PM
- INOVIO Announces Proposed Public Offering • PR Newswire (US) • 04/02/2026 12:05:00 AM
- INOVIO to Participate in Upcoming Scientific Conference • PR Newswire (US) • 04/01/2026 02:29:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 03/30/2026 07:47:00 AM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/12/2026 08:05:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/10/2026 01:00:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 03/09/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:55:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:54:42 PM
- INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • PR Newswire (US) • 03/05/2026 09:05:00 PM
- INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) • PR Newswire (US) • 03/04/2026 01:05:00 PM
- Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:44:20 PM
- Investors in Inovio Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 02/23/2026 09:04:00 AM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 02/20/2026 09:27:00 AM
